HBV and HCV infection in type 2 diabetes mellitus

A survey in three diabetes units in different Italian areas

Valentina Soverini, Marcello Persico, Elisabetta Bugianesi, Gabriele Forlani, Federico Salamone, Mario Massarone, Vincenzo La Mura, Arianna Mazzotti, Alberto Bruno, Giulio Marchesini

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Viral infections and the metabolic syndrome may coexist in several individuals, due to the large prevalence of obesity and type 2 diabetes mellitus (T2DM). Antiviral therapy has changed the natural history of chronic viral hepatitis, but viral infection may remain undiagnosed in the absence of systematic screening. We determined the prevalence of HBV and/or HCV infection in an Italian cohort with T2DM (859 consecutive patients, 413 females) in three Italian centers: Turin, Bologna, and Naples. Screening for viral disease was coupled with the determination of parameters of metabolic syndrome. Fourteen patients were HBsAg-positive, 51 anti-HCV with a prevalence of genotype-1 infection in 58% of cases. Thirty cases had newly diagnosed viral markers, only one-third had already-diagnosed liver disease, 16 were being followed-up by a Liver Unit, and 9 cases had received antiviral treatment. Patients with viral markers had higher liver enzyme levels in comparison with virus-negative patients (P <0.0001), whereas the prevalence of the metabolic syndrome was similar in the 2 groups. A positive correlation between BMI and alanine aminostransferase levels was only present in virus-negative cases, where the probability of enzyme levels above the upper limit of normal increased by 5% for unit of increase in BMI (OR: 1.05; 95% CI: 1.003-1.100, P = 0.037). In conclusion, the prevalence of HBV and HCV is non-negligible in patients with T2DM, but these cases may long remain undiagnosed. Elevated liver enzymes might be frequently disregarded in diabetes Units and ascribed to metabolic syndrome, thus excluding T2DM patients from specific disease-modifying antiviral treatment for hepatitis.

Original languageEnglish
Pages (from-to)337-343
Number of pages7
JournalActa Diabetologica
Volume48
Issue number4
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Type 2 Diabetes Mellitus
Virus Diseases
Infection
Antiviral Agents
Liver
Enzymes
Biomarkers
Viruses
Chronic Hepatitis
Hepatitis B Surface Antigens
Alanine
Hepatitis
Surveys and Questionnaires
Liver Diseases
Therapeutics
Obesity
Genotype

Keywords

  • Epidemiology
  • Liver enzymes
  • Metabolic syndrome
  • Type 2 diabetes
  • Viral infections

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Soverini, V., Persico, M., Bugianesi, E., Forlani, G., Salamone, F., Massarone, M., ... Marchesini, G. (2011). HBV and HCV infection in type 2 diabetes mellitus: A survey in three diabetes units in different Italian areas. Acta Diabetologica, 48(4), 337-343. https://doi.org/10.1007/s00592-011-0293-x

HBV and HCV infection in type 2 diabetes mellitus : A survey in three diabetes units in different Italian areas. / Soverini, Valentina; Persico, Marcello; Bugianesi, Elisabetta; Forlani, Gabriele; Salamone, Federico; Massarone, Mario; La Mura, Vincenzo; Mazzotti, Arianna; Bruno, Alberto; Marchesini, Giulio.

In: Acta Diabetologica, Vol. 48, No. 4, 12.2011, p. 337-343.

Research output: Contribution to journalArticle

Soverini, V, Persico, M, Bugianesi, E, Forlani, G, Salamone, F, Massarone, M, La Mura, V, Mazzotti, A, Bruno, A & Marchesini, G 2011, 'HBV and HCV infection in type 2 diabetes mellitus: A survey in three diabetes units in different Italian areas', Acta Diabetologica, vol. 48, no. 4, pp. 337-343. https://doi.org/10.1007/s00592-011-0293-x
Soverini, Valentina ; Persico, Marcello ; Bugianesi, Elisabetta ; Forlani, Gabriele ; Salamone, Federico ; Massarone, Mario ; La Mura, Vincenzo ; Mazzotti, Arianna ; Bruno, Alberto ; Marchesini, Giulio. / HBV and HCV infection in type 2 diabetes mellitus : A survey in three diabetes units in different Italian areas. In: Acta Diabetologica. 2011 ; Vol. 48, No. 4. pp. 337-343.
@article{5c67f561b1e04d73885fd580b83b80e7,
title = "HBV and HCV infection in type 2 diabetes mellitus: A survey in three diabetes units in different Italian areas",
abstract = "Viral infections and the metabolic syndrome may coexist in several individuals, due to the large prevalence of obesity and type 2 diabetes mellitus (T2DM). Antiviral therapy has changed the natural history of chronic viral hepatitis, but viral infection may remain undiagnosed in the absence of systematic screening. We determined the prevalence of HBV and/or HCV infection in an Italian cohort with T2DM (859 consecutive patients, 413 females) in three Italian centers: Turin, Bologna, and Naples. Screening for viral disease was coupled with the determination of parameters of metabolic syndrome. Fourteen patients were HBsAg-positive, 51 anti-HCV with a prevalence of genotype-1 infection in 58{\%} of cases. Thirty cases had newly diagnosed viral markers, only one-third had already-diagnosed liver disease, 16 were being followed-up by a Liver Unit, and 9 cases had received antiviral treatment. Patients with viral markers had higher liver enzyme levels in comparison with virus-negative patients (P <0.0001), whereas the prevalence of the metabolic syndrome was similar in the 2 groups. A positive correlation between BMI and alanine aminostransferase levels was only present in virus-negative cases, where the probability of enzyme levels above the upper limit of normal increased by 5{\%} for unit of increase in BMI (OR: 1.05; 95{\%} CI: 1.003-1.100, P = 0.037). In conclusion, the prevalence of HBV and HCV is non-negligible in patients with T2DM, but these cases may long remain undiagnosed. Elevated liver enzymes might be frequently disregarded in diabetes Units and ascribed to metabolic syndrome, thus excluding T2DM patients from specific disease-modifying antiviral treatment for hepatitis.",
keywords = "Epidemiology, Liver enzymes, Metabolic syndrome, Type 2 diabetes, Viral infections",
author = "Valentina Soverini and Marcello Persico and Elisabetta Bugianesi and Gabriele Forlani and Federico Salamone and Mario Massarone and {La Mura}, Vincenzo and Arianna Mazzotti and Alberto Bruno and Giulio Marchesini",
year = "2011",
month = "12",
doi = "10.1007/s00592-011-0293-x",
language = "English",
volume = "48",
pages = "337--343",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia s.r.l.",
number = "4",

}

TY - JOUR

T1 - HBV and HCV infection in type 2 diabetes mellitus

T2 - A survey in three diabetes units in different Italian areas

AU - Soverini, Valentina

AU - Persico, Marcello

AU - Bugianesi, Elisabetta

AU - Forlani, Gabriele

AU - Salamone, Federico

AU - Massarone, Mario

AU - La Mura, Vincenzo

AU - Mazzotti, Arianna

AU - Bruno, Alberto

AU - Marchesini, Giulio

PY - 2011/12

Y1 - 2011/12

N2 - Viral infections and the metabolic syndrome may coexist in several individuals, due to the large prevalence of obesity and type 2 diabetes mellitus (T2DM). Antiviral therapy has changed the natural history of chronic viral hepatitis, but viral infection may remain undiagnosed in the absence of systematic screening. We determined the prevalence of HBV and/or HCV infection in an Italian cohort with T2DM (859 consecutive patients, 413 females) in three Italian centers: Turin, Bologna, and Naples. Screening for viral disease was coupled with the determination of parameters of metabolic syndrome. Fourteen patients were HBsAg-positive, 51 anti-HCV with a prevalence of genotype-1 infection in 58% of cases. Thirty cases had newly diagnosed viral markers, only one-third had already-diagnosed liver disease, 16 were being followed-up by a Liver Unit, and 9 cases had received antiviral treatment. Patients with viral markers had higher liver enzyme levels in comparison with virus-negative patients (P <0.0001), whereas the prevalence of the metabolic syndrome was similar in the 2 groups. A positive correlation between BMI and alanine aminostransferase levels was only present in virus-negative cases, where the probability of enzyme levels above the upper limit of normal increased by 5% for unit of increase in BMI (OR: 1.05; 95% CI: 1.003-1.100, P = 0.037). In conclusion, the prevalence of HBV and HCV is non-negligible in patients with T2DM, but these cases may long remain undiagnosed. Elevated liver enzymes might be frequently disregarded in diabetes Units and ascribed to metabolic syndrome, thus excluding T2DM patients from specific disease-modifying antiviral treatment for hepatitis.

AB - Viral infections and the metabolic syndrome may coexist in several individuals, due to the large prevalence of obesity and type 2 diabetes mellitus (T2DM). Antiviral therapy has changed the natural history of chronic viral hepatitis, but viral infection may remain undiagnosed in the absence of systematic screening. We determined the prevalence of HBV and/or HCV infection in an Italian cohort with T2DM (859 consecutive patients, 413 females) in three Italian centers: Turin, Bologna, and Naples. Screening for viral disease was coupled with the determination of parameters of metabolic syndrome. Fourteen patients were HBsAg-positive, 51 anti-HCV with a prevalence of genotype-1 infection in 58% of cases. Thirty cases had newly diagnosed viral markers, only one-third had already-diagnosed liver disease, 16 were being followed-up by a Liver Unit, and 9 cases had received antiviral treatment. Patients with viral markers had higher liver enzyme levels in comparison with virus-negative patients (P <0.0001), whereas the prevalence of the metabolic syndrome was similar in the 2 groups. A positive correlation between BMI and alanine aminostransferase levels was only present in virus-negative cases, where the probability of enzyme levels above the upper limit of normal increased by 5% for unit of increase in BMI (OR: 1.05; 95% CI: 1.003-1.100, P = 0.037). In conclusion, the prevalence of HBV and HCV is non-negligible in patients with T2DM, but these cases may long remain undiagnosed. Elevated liver enzymes might be frequently disregarded in diabetes Units and ascribed to metabolic syndrome, thus excluding T2DM patients from specific disease-modifying antiviral treatment for hepatitis.

KW - Epidemiology

KW - Liver enzymes

KW - Metabolic syndrome

KW - Type 2 diabetes

KW - Viral infections

UR - http://www.scopus.com/inward/record.url?scp=84355166763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84355166763&partnerID=8YFLogxK

U2 - 10.1007/s00592-011-0293-x

DO - 10.1007/s00592-011-0293-x

M3 - Article

VL - 48

SP - 337

EP - 343

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 4

ER -